Peps
What is Semax?
Semax is a seven-amino-acid peptide investigated in neurobiological research. The selected study examines responses to experimental brain ischemia.
Biological role or research focus
Neurobiological and cerebral-ischemia research.
Animal brain findings do not demonstrate improved focus or mood in otherwise healthy people.
- Class / identity
- Experimental neuroactive heptapeptide
- Main research area
- Brain-ischemia biology
- Evidence featured
- Rat brain experiment
- Source check
- October 4, 2026
Molecular structure
Mechanism & research rationale
Researchers measured changes in immune- and vascular-related gene expression after injury. These molecular responses suggest pathways for investigation, not a verified cognitive-enhancement effect.
Research context & status
This page presents a rat-brain experiment. It does not establish an everyday focus, mood, or memory indication in healthy people.
What does the evidence show?
Selected published evidence, with the population, findings, and limits kept together. These original summaries draw on publication abstracts; they are not a systematic review.
Rat brain experiment · 2014
Ischemia transcriptome study
The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis.
- Population / model
- Rats after experimentally induced focal cerebral ischemia.
- Study design
- Brain-cortex gene expression measured three and 24 hours after arterial occlusion.
- Main finding
- Semax altered expression of immune- and vascular-system genes, including chemokine and immunoglobulin-related pathways.
- Limits & context
- Gene-expression changes do not demonstrate improved everyday attention, memory, or mood in healthy humans. The experiment models a brain injury and does not establish a clinical benefit-risk balance.
Human comparative study · 1997
Semax · early clinical stroke report
What clinical evidence accompanies the animal mechanism research?
- Population / model
- 30 treated patients with acute hemispheric ischemic stroke and 80 controls described as having comparable lesion location and severity.
- Study design
- Clinical scales, EEG, and somatosensory evoked potentials alongside conventional intensive therapy. Randomization and blinding are not stated in the abstract.
- Main finding
- The authors reported faster regression of neurological deficits, especially motor impairment, with added Semax; numerical treatment effects and confidence intervals are not provided.
- How to read it
- A comparative clinical report is a different evidence level from a well-described blinded randomized trial.
- Limits & context
- Unequal groups, unclear allocation, and limited reporting leave substantial uncertainty. The Russian-language methods require review. Acute stroke findings cannot establish memory enhancement in healthy people or modern clinical practice recommendations.
Read the original paper for methods, adverse events, funding, and conflicts of interest. Publisher access may require a subscription.
Search additional PubMed records ↗New editorial updates
New source discoveries
Links appear automatically. Unreviewed discoveries are not verified medical findings.
Safety & precautions
Safety evidence & remaining uncertainty
FDA describes limited route-specific safety evidence. Gene-expression experiments cannot establish tolerability, drug interactions, or long-term neurological safety in people.
Source: FDA · Peptide compounding safety concerns ↗
This is not a complete list of contraindications, interactions, or adverse effects. Medicine labels apply to specific products and indications; research-use listings are not interchangeable with approved medicines.
What are people discussing?
Personal reports of focus and mood
The host reports perceived improvements in focus and mood and asks the guest for an explanation. The guest acknowledges that research populations differ from healthy people seeking optimization.
Is the proposed benefit supported by trials in the same population, rather than a personal account?
Caption excerpt reviewed · Claims not independently verified · 2026-10-04
Original episode: PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast
Proposed neurochemical explanations
The conversation links these neuropeptides to the host’s experience, then proposes neurotransmitter and growth-factor explanations for Semax. These mechanistic claims need separate study-level verification.
Are the proposed mechanism and meaningful clinical outcome both demonstrated in humans?
Caption excerpt reviewed · Claims not independently verified · 2026-10-04
Original episode: PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast
Watch the source discussions
15 matching video records · 3 with captions indexed.
Across the full library, 30 caption files are indexed from 20,199 inventoried videos. Most transcripts remain unreviewed. Select a thumbnail or timestamp to watch inside PepsRadar. Thumbnail images load from YouTube.
Fouad Abiad Media
PEPTIDES FOR ANXIETY? |SEMAX & SELANK | Real Bodybuilding Podcast ↗
Captions indexed · Automatic matches need review
Fouad Abiad Media
RETATRUTIDE: EVERYTHING YOU NEED TO KNOW | Wes Christensen | Fouad Abiad's Real Bodybuilding Podcast ↗
Captions indexed · Automatic matches need review
Peptide Of The Week
Telehealth vs Research Peptides: The Truth Nobody Tells You | Peptide of the Week Q&A #61 ↗
Captions indexed · Automatic matches need review
Biohackingturkey
30 Günlük Semax ve Selank Deneyi: Bunu Beklemiyordum! ↗
Title match · Captions not indexed
Biohackingturkey
Semax + Selank Kombinasyonu: Bilmeniz Gereken 5 Etki ↗
Title match · Captions not indexed
Biohackingturkey
Semax Peptidi Nedir? Beyninizi Uçuracak Rus Sırrı! ↗
Title match · Captions not indexed
Sources & supplier listings
Listings are grouped by the vendor’s stated identity. Blends and modified derivatives are labeled separately. Inclusion is not a quality assessment or an endorsement.
N-Acetyl Semax Amidate (20mg)
BioLongevity Labs · Vendor-labeled research use only
$64.97
Listed in stock · Snapshot 2026-10-04
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
SEMAX (10 mg)
American Peptides · Vendor-labeled research use only
$65.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
SELANK + SEMAX (5 mg / 5 mg)
American Peptides · Vendor-labeled research use only
$70.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
ADAMAX (10 mg)
American Peptides · Vendor-labeled research use only
$90.00
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Semax (11 mg)
PSPeptides · Vendor-labeled research use only
$42.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Selank+Semax Blend (10 mg - 5/5 mg / 40 mg - 30/10 mg)
PSPeptides · Vendor-labeled research use only
$54.99–$129.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Adamax (10 mg)
PSPeptides · Vendor-labeled research use only
$65.99
Listed in stock · Snapshot 2026-10-05
Options may vary. Shipping and tax excluded.
Affiliate link · PepsRadar may earn a commission from purchases through this link. Affiliate disclosure.
Catalog checked 2026-10-04. Seller listings retain their stated intended use. Shops covered: BioLongevity Labs, BioLongevity Supplements, American Peptides, PSPeptides. This is not a market-wide comparison. Affiliate participation does not determine evidence or editorial coverage.
Questions worth asking
- What specific product, route, and research population does the claim refer to?
- Does the source measure an outcome in people, or only a laboratory marker?
- Animal brain findings do not demonstrate improved focus or mood in otherwise healthy people.
- What adverse effects, uncertainty, and conflicts of interest does the original source report?
Frequently asked questions
Was the experiment performed in healthy people seeking focus?
No. It used rats after induced cerebral ischemia.
Does a gene-expression change show better brain function?
Not by itself. Functional recovery and meaningful clinical outcomes require separate measurements.
References & editorial record
- FDA · Compounding safety concerns ↗
- PubMed · Rat cerebral-ischemia model · PMID 24661604 ↗
- Semax · early clinical stroke report · 1997 ↗
Source notes checked 2026-10-04. Original PepsRadar summaries. Not reviewed by a medical professional. Topic grouping is editorial navigation, not a treatment recommendation. Video notes specify which excerpts were reviewed; no full transcripts are published.